Biosensor Systems Design

Biosensor Systems Design is a biotechnology company dedicated to the innovation of advanced optical biosensing technologies for medical applications. The company specializes in the development of affinity-based sensors that utilize competitive binding assays and fiber-optic fluorescence to monitor physiological analytes in real-time. Their primary focus has been the creation of a continuous glucose monitoring (CGM) system designed to improve the management of diabetes through enhanced sensor stability and accuracy. Supported by significant Small Business Innovation Research (SBIR) funding, the firm bridges the gap between academic research in bioengineering and commercial medical device development. Their platform technology is engineered to be adaptable for various metabolic markers beyond glucose, offering potential applications in critical care and environmental monitoring.